Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation
Astrocytes have critical roles in the human CNS in health and disease. They provide trophic support to neurons and are innate-immune cells with keys roles during states-of-inflammation. In addition, they have integral functions associated with maintaining the integrity of the blood-brain barrier. We...
Gespeichert in:
Veröffentlicht in: | PloS one 2013-12, Vol.8 (12), p.e84269 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 12 |
container_start_page | e84269 |
container_title | PloS one |
container_volume | 8 |
creator | van Kralingen, Christa Kho, Dan Ting Costa, Jessica Angel, Catherine Elizabeth Graham, E Scott |
description | Astrocytes have critical roles in the human CNS in health and disease. They provide trophic support to neurons and are innate-immune cells with keys roles during states-of-inflammation. In addition, they have integral functions associated with maintaining the integrity of the blood-brain barrier.
We have used cytometric bead arrays and xCELLigence technology to monitor the to monitor the inflammatory response profiles and astrocyte compromise in real-time under various inflammatory conditions. Responses were compared to a variety of inflammatory cytokines known to be released in the CNS during neuroinflammation. Astrocyte compromise measured by xCELLigence was confirmed using ATP measurements, cleaved caspase 3 expression, assessment of nuclear morphology and cell death.
Inflammatory activation (IL-1β or TNFα) of astrocytes results in the transient production of key inflammatory mediators including IL-6, cell surface adhesion molecules, and various leukocyte chemoattractants. Following this phase, the NT2-astrocytes progressively become compromised, which is indicated by a loss of adhesion, appearance of apoptotic nuclei and reduction in ATP levels, followed by DEATH. The earliest signs of astrocyte compromise were observed between 24-48 h post cytokine treatment. However, significant cell loss was not observed until at least 72 h, where there was also an increase in the expression of cleaved-caspase 3. By 96 hours approximately 50% of the astrocytes were dead, with many of the remaining showing signs of compromise too. Numerous other inflammatory factors were tested, however these effects were only observed with IL-1β or TNFα treatment.
Here we reveal direct sensitivity to mediators of the inflammatory milieu. We highlight the power of xCELLigence technology for revealing the early progressive compromise of the astrocytes, which occurs 24-48 hours prior to substantive cell loss. Death induced by IL-1β or TNFα is relevant clinically as these two cytokines are produced by various peripheral tissues and by resident brain cells. |
doi_str_mv | 10.1371/journal.pone.0084269 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1469701763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478214963</galeid><doaj_id>oai_doaj_org_article_2733dbfdedd0437aaee0e862327ee805</doaj_id><sourcerecordid>A478214963</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-b2cfb880e3b35a4a3da497471864a83d475721bc5dbd4701a9ebbb907ce4cd053</originalsourceid><addsrcrecordid>eNqNk-GK1DAQx4so3nn6BqIBQfDDrmmTbVIOhOO404XFAz39GtJkupuzbWqSyu0r-Db6IPdMZnd7yxYUpB8aMr__zPDPTJI8T_E0JSx9e2N718p62tkWphhzmuXFg-Q4LUg2yTNMHh6cj5In3t9gPCM8zx8nRxklOcspP05-Xtx21vcOULDItFUtm0YG69ZIrYP9ZlrwaL6YpHe_kWw1uv54efcrcrpXMaBs0znbGA_boAYZVshWSPrgbNSDP0Wm6WqjZDC29aiyDqmVs61RqIXe2X3FGH6aPKpk7eHZ8D9JvlxeXJ9_mCyu3s_PzxYTlRdZmJSZqkrOMZCSzCSVREtaMMpSnlPJiaZsxrK0VDNdxjNOZQFlWRaYKaBKRwtOkpe7vF1tvRhs9CKleRFxlpNIzHeEtvJGdM400q2FlUZsL6xbCumCUTWIjBGiy0qD1pgSJiUABp5nJGMAfFvt3VCtLxvQCtrgZD1KOo60ZiWW9oeIT8VnfNPMqyGBs9978OEfLQ_UUsauoq02JlPxaZQ4o4xnKS221PQvVPw0NEbFQapMvB8J3owEkQlwG5ay917MP3_6f_bq65h9fcCuQNZh5W3db8dkDNIdqJz13kG1dy7FYrMH926IzR6IYQ-i7MWh63vR_eCTPwILB8M</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1469701763</pqid></control><display><type>article</type><title>Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>van Kralingen, Christa ; Kho, Dan Ting ; Costa, Jessica ; Angel, Catherine Elizabeth ; Graham, E Scott</creator><contributor>Tansey, Malú G.</contributor><creatorcontrib>van Kralingen, Christa ; Kho, Dan Ting ; Costa, Jessica ; Angel, Catherine Elizabeth ; Graham, E Scott ; Tansey, Malú G.</creatorcontrib><description>Astrocytes have critical roles in the human CNS in health and disease. They provide trophic support to neurons and are innate-immune cells with keys roles during states-of-inflammation. In addition, they have integral functions associated with maintaining the integrity of the blood-brain barrier.
We have used cytometric bead arrays and xCELLigence technology to monitor the to monitor the inflammatory response profiles and astrocyte compromise in real-time under various inflammatory conditions. Responses were compared to a variety of inflammatory cytokines known to be released in the CNS during neuroinflammation. Astrocyte compromise measured by xCELLigence was confirmed using ATP measurements, cleaved caspase 3 expression, assessment of nuclear morphology and cell death.
Inflammatory activation (IL-1β or TNFα) of astrocytes results in the transient production of key inflammatory mediators including IL-6, cell surface adhesion molecules, and various leukocyte chemoattractants. Following this phase, the NT2-astrocytes progressively become compromised, which is indicated by a loss of adhesion, appearance of apoptotic nuclei and reduction in ATP levels, followed by DEATH. The earliest signs of astrocyte compromise were observed between 24-48 h post cytokine treatment. However, significant cell loss was not observed until at least 72 h, where there was also an increase in the expression of cleaved-caspase 3. By 96 hours approximately 50% of the astrocytes were dead, with many of the remaining showing signs of compromise too. Numerous other inflammatory factors were tested, however these effects were only observed with IL-1β or TNFα treatment.
Here we reveal direct sensitivity to mediators of the inflammatory milieu. We highlight the power of xCELLigence technology for revealing the early progressive compromise of the astrocytes, which occurs 24-48 hours prior to substantive cell loss. Death induced by IL-1β or TNFα is relevant clinically as these two cytokines are produced by various peripheral tissues and by resident brain cells.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0084269</identifier><identifier>PMID: 24367648</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adhesion ; Adhesive strength ; Apoptosis ; Astrocytes ; Astrocytes - cytology ; Astrocytes - drug effects ; Astrocytes - metabolism ; Astrocytes - pathology ; ATP ; Blood-brain barrier ; Brain research ; Caspase ; Caspase 3 - metabolism ; Caspase-3 ; Cell activation ; Cell Adhesion - drug effects ; Cell adhesion molecules ; Cell cycle ; Cell death ; Cell Death - drug effects ; Cell Differentiation - drug effects ; Cell Line ; Cell Nucleus - drug effects ; Cell surface ; Central nervous system ; Chemokines ; Chemotactic factors ; Chronic Disease ; Comparative analysis ; Cytokines ; Cytology ; Dose-Response Relationship, Drug ; Gene Expression Regulation, Enzymologic - drug effects ; Health sciences ; Hostages ; Humans ; Immune system ; Immunoglobulins ; Inflammation ; Inflammation - metabolism ; Inflammation - pathology ; Inflammatory response ; Interleukin 6 ; Interleukin-1beta - pharmacology ; Interleukin-1beta - secretion ; Leukocytes ; Mortality ; Multiple sclerosis ; Nerve Tissue Proteins - metabolism ; Nervous system ; Neurons ; Neurotrophin 2 ; Technology ; Time Factors ; Tissues ; Tumor necrosis factor ; Tumor Necrosis Factor-alpha - pharmacology ; Tumor Necrosis Factor-alpha - secretion ; Tumor necrosis factor-TNF ; Tumor necrosis factor-α</subject><ispartof>PloS one, 2013-12, Vol.8 (12), p.e84269</ispartof><rights>COPYRIGHT 2013 Public Library of Science</rights><rights>2013 van Kralingen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2013 van Kralingen et al 2013 van Kralingen et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-b2cfb880e3b35a4a3da497471864a83d475721bc5dbd4701a9ebbb907ce4cd053</citedby><cites>FETCH-LOGICAL-c692t-b2cfb880e3b35a4a3da497471864a83d475721bc5dbd4701a9ebbb907ce4cd053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868583/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868583/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24367648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Tansey, Malú G.</contributor><creatorcontrib>van Kralingen, Christa</creatorcontrib><creatorcontrib>Kho, Dan Ting</creatorcontrib><creatorcontrib>Costa, Jessica</creatorcontrib><creatorcontrib>Angel, Catherine Elizabeth</creatorcontrib><creatorcontrib>Graham, E Scott</creatorcontrib><title>Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Astrocytes have critical roles in the human CNS in health and disease. They provide trophic support to neurons and are innate-immune cells with keys roles during states-of-inflammation. In addition, they have integral functions associated with maintaining the integrity of the blood-brain barrier.
We have used cytometric bead arrays and xCELLigence technology to monitor the to monitor the inflammatory response profiles and astrocyte compromise in real-time under various inflammatory conditions. Responses were compared to a variety of inflammatory cytokines known to be released in the CNS during neuroinflammation. Astrocyte compromise measured by xCELLigence was confirmed using ATP measurements, cleaved caspase 3 expression, assessment of nuclear morphology and cell death.
Inflammatory activation (IL-1β or TNFα) of astrocytes results in the transient production of key inflammatory mediators including IL-6, cell surface adhesion molecules, and various leukocyte chemoattractants. Following this phase, the NT2-astrocytes progressively become compromised, which is indicated by a loss of adhesion, appearance of apoptotic nuclei and reduction in ATP levels, followed by DEATH. The earliest signs of astrocyte compromise were observed between 24-48 h post cytokine treatment. However, significant cell loss was not observed until at least 72 h, where there was also an increase in the expression of cleaved-caspase 3. By 96 hours approximately 50% of the astrocytes were dead, with many of the remaining showing signs of compromise too. Numerous other inflammatory factors were tested, however these effects were only observed with IL-1β or TNFα treatment.
Here we reveal direct sensitivity to mediators of the inflammatory milieu. We highlight the power of xCELLigence technology for revealing the early progressive compromise of the astrocytes, which occurs 24-48 hours prior to substantive cell loss. Death induced by IL-1β or TNFα is relevant clinically as these two cytokines are produced by various peripheral tissues and by resident brain cells.</description><subject>Adhesion</subject><subject>Adhesive strength</subject><subject>Apoptosis</subject><subject>Astrocytes</subject><subject>Astrocytes - cytology</subject><subject>Astrocytes - drug effects</subject><subject>Astrocytes - metabolism</subject><subject>Astrocytes - pathology</subject><subject>ATP</subject><subject>Blood-brain barrier</subject><subject>Brain research</subject><subject>Caspase</subject><subject>Caspase 3 - metabolism</subject><subject>Caspase-3</subject><subject>Cell activation</subject><subject>Cell Adhesion - drug effects</subject><subject>Cell adhesion molecules</subject><subject>Cell cycle</subject><subject>Cell death</subject><subject>Cell Death - drug effects</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Line</subject><subject>Cell Nucleus - drug effects</subject><subject>Cell surface</subject><subject>Central nervous system</subject><subject>Chemokines</subject><subject>Chemotactic factors</subject><subject>Chronic Disease</subject><subject>Comparative analysis</subject><subject>Cytokines</subject><subject>Cytology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gene Expression Regulation, Enzymologic - drug effects</subject><subject>Health sciences</subject><subject>Hostages</subject><subject>Humans</subject><subject>Immune system</subject><subject>Immunoglobulins</subject><subject>Inflammation</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - pathology</subject><subject>Inflammatory response</subject><subject>Interleukin 6</subject><subject>Interleukin-1beta - pharmacology</subject><subject>Interleukin-1beta - secretion</subject><subject>Leukocytes</subject><subject>Mortality</subject><subject>Multiple sclerosis</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Nervous system</subject><subject>Neurons</subject><subject>Neurotrophin 2</subject><subject>Technology</subject><subject>Time Factors</subject><subject>Tissues</subject><subject>Tumor necrosis factor</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Tumor Necrosis Factor-alpha - secretion</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumor necrosis factor-α</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk-GK1DAQx4so3nn6BqIBQfDDrmmTbVIOhOO404XFAz39GtJkupuzbWqSyu0r-Db6IPdMZnd7yxYUpB8aMr__zPDPTJI8T_E0JSx9e2N718p62tkWphhzmuXFg-Q4LUg2yTNMHh6cj5In3t9gPCM8zx8nRxklOcspP05-Xtx21vcOULDItFUtm0YG69ZIrYP9ZlrwaL6YpHe_kWw1uv54efcrcrpXMaBs0znbGA_boAYZVshWSPrgbNSDP0Wm6WqjZDC29aiyDqmVs61RqIXe2X3FGH6aPKpk7eHZ8D9JvlxeXJ9_mCyu3s_PzxYTlRdZmJSZqkrOMZCSzCSVREtaMMpSnlPJiaZsxrK0VDNdxjNOZQFlWRaYKaBKRwtOkpe7vF1tvRhs9CKleRFxlpNIzHeEtvJGdM400q2FlUZsL6xbCumCUTWIjBGiy0qD1pgSJiUABp5nJGMAfFvt3VCtLxvQCtrgZD1KOo60ZiWW9oeIT8VnfNPMqyGBs9978OEfLQ_UUsauoq02JlPxaZQ4o4xnKS221PQvVPw0NEbFQapMvB8J3owEkQlwG5ay917MP3_6f_bq65h9fcCuQNZh5W3db8dkDNIdqJz13kG1dy7FYrMH926IzR6IYQ-i7MWh63vR_eCTPwILB8M</recordid><startdate>20131219</startdate><enddate>20131219</enddate><creator>van Kralingen, Christa</creator><creator>Kho, Dan Ting</creator><creator>Costa, Jessica</creator><creator>Angel, Catherine Elizabeth</creator><creator>Graham, E Scott</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20131219</creationdate><title>Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation</title><author>van Kralingen, Christa ; Kho, Dan Ting ; Costa, Jessica ; Angel, Catherine Elizabeth ; Graham, E Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-b2cfb880e3b35a4a3da497471864a83d475721bc5dbd4701a9ebbb907ce4cd053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adhesion</topic><topic>Adhesive strength</topic><topic>Apoptosis</topic><topic>Astrocytes</topic><topic>Astrocytes - cytology</topic><topic>Astrocytes - drug effects</topic><topic>Astrocytes - metabolism</topic><topic>Astrocytes - pathology</topic><topic>ATP</topic><topic>Blood-brain barrier</topic><topic>Brain research</topic><topic>Caspase</topic><topic>Caspase 3 - metabolism</topic><topic>Caspase-3</topic><topic>Cell activation</topic><topic>Cell Adhesion - drug effects</topic><topic>Cell adhesion molecules</topic><topic>Cell cycle</topic><topic>Cell death</topic><topic>Cell Death - drug effects</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Line</topic><topic>Cell Nucleus - drug effects</topic><topic>Cell surface</topic><topic>Central nervous system</topic><topic>Chemokines</topic><topic>Chemotactic factors</topic><topic>Chronic Disease</topic><topic>Comparative analysis</topic><topic>Cytokines</topic><topic>Cytology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gene Expression Regulation, Enzymologic - drug effects</topic><topic>Health sciences</topic><topic>Hostages</topic><topic>Humans</topic><topic>Immune system</topic><topic>Immunoglobulins</topic><topic>Inflammation</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - pathology</topic><topic>Inflammatory response</topic><topic>Interleukin 6</topic><topic>Interleukin-1beta - pharmacology</topic><topic>Interleukin-1beta - secretion</topic><topic>Leukocytes</topic><topic>Mortality</topic><topic>Multiple sclerosis</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Nervous system</topic><topic>Neurons</topic><topic>Neurotrophin 2</topic><topic>Technology</topic><topic>Time Factors</topic><topic>Tissues</topic><topic>Tumor necrosis factor</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Tumor Necrosis Factor-alpha - secretion</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Kralingen, Christa</creatorcontrib><creatorcontrib>Kho, Dan Ting</creatorcontrib><creatorcontrib>Costa, Jessica</creatorcontrib><creatorcontrib>Angel, Catherine Elizabeth</creatorcontrib><creatorcontrib>Graham, E Scott</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Kralingen, Christa</au><au>Kho, Dan Ting</au><au>Costa, Jessica</au><au>Angel, Catherine Elizabeth</au><au>Graham, E Scott</au><au>Tansey, Malú G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-12-19</date><risdate>2013</risdate><volume>8</volume><issue>12</issue><spage>e84269</spage><pages>e84269-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Astrocytes have critical roles in the human CNS in health and disease. They provide trophic support to neurons and are innate-immune cells with keys roles during states-of-inflammation. In addition, they have integral functions associated with maintaining the integrity of the blood-brain barrier.
We have used cytometric bead arrays and xCELLigence technology to monitor the to monitor the inflammatory response profiles and astrocyte compromise in real-time under various inflammatory conditions. Responses were compared to a variety of inflammatory cytokines known to be released in the CNS during neuroinflammation. Astrocyte compromise measured by xCELLigence was confirmed using ATP measurements, cleaved caspase 3 expression, assessment of nuclear morphology and cell death.
Inflammatory activation (IL-1β or TNFα) of astrocytes results in the transient production of key inflammatory mediators including IL-6, cell surface adhesion molecules, and various leukocyte chemoattractants. Following this phase, the NT2-astrocytes progressively become compromised, which is indicated by a loss of adhesion, appearance of apoptotic nuclei and reduction in ATP levels, followed by DEATH. The earliest signs of astrocyte compromise were observed between 24-48 h post cytokine treatment. However, significant cell loss was not observed until at least 72 h, where there was also an increase in the expression of cleaved-caspase 3. By 96 hours approximately 50% of the astrocytes were dead, with many of the remaining showing signs of compromise too. Numerous other inflammatory factors were tested, however these effects were only observed with IL-1β or TNFα treatment.
Here we reveal direct sensitivity to mediators of the inflammatory milieu. We highlight the power of xCELLigence technology for revealing the early progressive compromise of the astrocytes, which occurs 24-48 hours prior to substantive cell loss. Death induced by IL-1β or TNFα is relevant clinically as these two cytokines are produced by various peripheral tissues and by resident brain cells.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24367648</pmid><doi>10.1371/journal.pone.0084269</doi><tpages>e84269</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2013-12, Vol.8 (12), p.e84269 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1469701763 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Adhesion Adhesive strength Apoptosis Astrocytes Astrocytes - cytology Astrocytes - drug effects Astrocytes - metabolism Astrocytes - pathology ATP Blood-brain barrier Brain research Caspase Caspase 3 - metabolism Caspase-3 Cell activation Cell Adhesion - drug effects Cell adhesion molecules Cell cycle Cell death Cell Death - drug effects Cell Differentiation - drug effects Cell Line Cell Nucleus - drug effects Cell surface Central nervous system Chemokines Chemotactic factors Chronic Disease Comparative analysis Cytokines Cytology Dose-Response Relationship, Drug Gene Expression Regulation, Enzymologic - drug effects Health sciences Hostages Humans Immune system Immunoglobulins Inflammation Inflammation - metabolism Inflammation - pathology Inflammatory response Interleukin 6 Interleukin-1beta - pharmacology Interleukin-1beta - secretion Leukocytes Mortality Multiple sclerosis Nerve Tissue Proteins - metabolism Nervous system Neurons Neurotrophin 2 Technology Time Factors Tissues Tumor necrosis factor Tumor Necrosis Factor-alpha - pharmacology Tumor Necrosis Factor-alpha - secretion Tumor necrosis factor-TNF Tumor necrosis factor-α |
title | Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A39%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exposure%20to%20inflammatory%20cytokines%20IL-1%CE%B2%20and%20TNF%CE%B1%20induces%20compromise%20and%20death%20of%20astrocytes;%20implications%20for%20chronic%20neuroinflammation&rft.jtitle=PloS%20one&rft.au=van%20Kralingen,%20Christa&rft.date=2013-12-19&rft.volume=8&rft.issue=12&rft.spage=e84269&rft.pages=e84269-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0084269&rft_dat=%3Cgale_plos_%3EA478214963%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1469701763&rft_id=info:pmid/24367648&rft_galeid=A478214963&rft_doaj_id=oai_doaj_org_article_2733dbfdedd0437aaee0e862327ee805&rfr_iscdi=true |